<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">jkstn</journal-id>
<journal-title-group>
<journal-title>The Journal of the Korean Society for Transplantation</journal-title>
<abbrev-journal-title>J Korean Soc Transplant</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1598-1711</issn>
<publisher>
<publisher-name>The Korean Society for Transplantation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.4285/jkstn.2010.24.4.298</article-id>
<article-id pub-id-type="publisher-id">jkstn-24-298</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Expression of E-cadherin, Heat Shock Protein 47, Transforming Growth Factor &#x03B2;1 and C4d in Chronic Allograft Nephropathy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Ki</surname><given-names>Won Chun</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkstn-24-298"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Jun</surname><given-names>Ho Park</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkstn-24-298"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Jin</surname><given-names>Cheol Jung</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkstn-24-298"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Doo</surname><given-names>Jin Kim</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkstn-24-298"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Sung</surname><given-names>Gil Park</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkstn-24-298"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Joo</surname><given-names>Seop Kim</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkstn-24-298"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Eun</surname><given-names>Suk Nam</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff2-jkstn-24-298"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Suk</surname><given-names>Ja Hyun</given-names></name><degrees>R.N.</degrees>
<xref ref-type="aff" rid="aff3-jkstn-24-298"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Lee</surname><given-names>Samuel</given-names></name><degrees>M.D.</degrees>
<xref ref-type="corresp" rid="c1-jkstn-24-298"/>
<xref ref-type="aff" rid="aff1-jkstn-24-298"><sup>1</sup></xref>
</contrib>
<aff id="aff1-jkstn-24-298"><label>1</label>Departments of Surgery, Kang-dong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, <country>Korea</country></aff>
<aff id="aff2-jkstn-24-298"><label>2</label>Pathology, Kang-dong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, <country>Korea</country></aff>
<aff id="aff3-jkstn-24-298"><label>3</label>Transplantation Center, Kang-dong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, <country>Korea</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-jkstn-24-298">&#xCC45;&#xC784;&#xC800;&#xC790;&#xFF1A;&#xC774;&#xC0BC;&#xC5F4;, &#xC11C;&#xC6B8;&#xC2DC; &#xAC15;&#xB3D9;&#xAD6C; &#xC131;&#xB0B4;&#xAE38; 150&#xD55C;&#xB9BC;&#xB300;&#xD559;&#xAD50; &#xAC15;&#xB3D9;&#xC131;&#xC2EC;&#xBCD1;&#xC6D0; &#xC678;&#xACFC;, 134-010 Tel: 02-2224-2222, Fax: 02-2224-2570 E-mail: <email>slee@hallym.or.kr</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>01</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>12</month>
<year>2010</year>
</pub-date>
<volume>24</volume>
<issue>4</issue>
<fpage>298</fpage>
<lpage>305</lpage>
<permissions>
<copyright-statement>Copyright &#x00A9; 2010 The Korean Society for Transplantation</copyright-statement>
<copyright-year>2010</copyright-year>
<license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license>
</permissions>
<abstract xml:lang="en">
<title>Abstract</title>
<sec>
<title>Background</title>
<p>Chronic allograft nephropathy (CAN), which causes graft failure, is related to tubular atrophy and interstitial fibrosis. E-cadherin is a well-known epithelial marker and heat shock protein (HSP)-47 is a collagen-specific molecular chaperone that regulates collagen synthesis. Transforming growth factor (TGF)-&#x03B2;1, a profibrotic cytokine, downregulates E-cadherin and induces expression of mesenchymal markers in an in vitro model. C4d expression is considered a poor prognostic marker for graft survival. This study evaluated the relationship between the expression of E-cadherin, HSP47, TGF-&#x03B2;1, and C4d with the prognosis for CAN.</p>
</sec>
<sec>
<title>Methods</title>
<p>Between March 1991 and August 2007, we performed renal allograft biopsies on 42 recipients with deteriorating renal function. CAN was diagnosed according to the chronic allograft damage index (Banff classification). Renal allograft biopsies were examined for the expression of E-cadherin, HSP47, TGF-&#x03B2;1, or C4d by immunohistochemistry. The HSP47, TGF-&#x03B2;1, and E-cadherin staining was scored semiquantitatively by analyzing ten different fields of cortical interstitium and tubules. Biopsies with endothelial C4d staining in peritubular capillaries (&#x2265;25&#x0025;) were designated as C4d-positive.</p>
</sec>
<sec>
<title>Results</title>
<p>Of 42 recipients, 17 (40.5&#x0025;) were in the graft survival group (GS) and 25 (59.5&#x0025;) were in the graft failure group (GF). E-cadherin expression in tubular cells of the GS was much higher than that of the GF (94.1&#x0025; vs 52&#x0025;, <italic>P</italic>&#x003D;0.04). HSP47 expression in tubular cells and interstitium in the GF was much higher than that in the GS (84&#x0025; vs 35.3&#x0025;, <italic>P</italic>&#x003D;0.001). TGF-&#x03B2;1 expression in tubular cells and interstitium in the GF was much higher than that in the GS (72&#x0025; vs 23.5&#x0025;, <italic>P</italic>&#x003D;0.02).</p>
</sec>
<sec>
<title>Conclusions</title>
<p>E-cadherin, HSP47, and TGF-&#x03B2;1 expression was strongly correlated with the CAN prognosis.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<kwd>E-cadherin</kwd>
<kwd>HSP47</kwd>
<kwd>TGF-&#x03B2; 1</kwd>
<kwd>Chronic allograft nephropathy</kwd>
</kwd-group>
</article-meta>
</front>
<back>
<ref-list xml:lang="en">
<title>References</title>
<ref id="b1-jkstn-24-298"><label>1)</label><element-citation publication-type="book"><collab>United States Renal Data System</collab> <source>USRDS 2003 annual data report: atlas of end-stage renal disease in the United States</source> <publisher-loc>Bethesda, MD.</publisher-loc> <publisher-name>National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases</publisher-name> <year>2003</year> <fpage>1</fpage><lpage>560</lpage></element-citation></ref>
<ref id="b2-jkstn-24-298"><label>2)</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>In Danovitch</surname> <given-names>GM</given-names></name></person-group> <source>Handbook of kidney transplantation</source> <edition>4th ed.</edition> <publisher-loc>Philadelphia</publisher-loc> <publisher-name>Lippincott Williams &#x0026; Wilkins</publisher-name> <year>2005</year><comment>: 242.</comment></element-citation></ref>
<ref id="b3-jkstn-24-298"><label>3)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreis</surname> <given-names>HA</given-names></name> <name><surname>Ponticelli</surname> <given-names>C</given-names></name></person-group> <article-title>Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors</article-title> <source>Transplantation</source> <year>2001</year><volume>71</volume> <issue>11 Suppl</issue> <fpage>SS5</fpage><lpage>9</lpage></element-citation></ref>
<ref id="b4-jkstn-24-298"><label>4)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vongwiwatana</surname> <given-names>A</given-names></name> <name><surname>Tasanarong</surname> <given-names>A</given-names></name> <name><surname>Rayner</surname> <given-names>DC</given-names></name> <name><surname>Melk</surname> <given-names>A</given-names></name> <name><surname>Halloran</surname> <given-names>PF</given-names></name></person-group> <article-title>Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells infibrogenesis</article-title> <source>Am J Transplant</source> <year>2005</year><volume>5</volume> <fpage>1367</fpage><lpage>74</lpage></element-citation></ref>
<ref id="b5-jkstn-24-298"><label>5)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohba</surname> <given-names>K</given-names></name> <name><surname>Miyata</surname> <given-names>Y</given-names></name> <name><surname>Koga</surname> <given-names>S</given-names></name> <name><surname>Nishikido</surname> <given-names>M</given-names></name> <name><surname>Kanetake</surname> <given-names>H</given-names></name> <name><surname>Nazneen</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Interstitial expression of heat-shock protein 47 correlates with capillary deposition of complement split product C4d in chronic allograft nephropathy</article-title> <source>Clin Transplant</source> <year>2005</year><volume>19</volume> <fpage>810</fpage><lpage>6</lpage></element-citation></ref>
<ref id="b6-jkstn-24-298"><label>6)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razzaque</surname> <given-names>MS</given-names></name> <name><surname>Kumatori</surname> <given-names>A</given-names></name> <name><surname>Harada</surname> <given-names>T</given-names></name> <name><surname>Taguchi</surname> <given-names>T</given-names></name></person-group> <article-title>Coexpression of collagens and collagen-binding heat shock protein 47 in human diabetic nephropathy and IgA nephropathy</article-title> <source>Nephron</source> <year>1998</year><volume>80</volume> <fpage>434</fpage><lpage>43</lpage></element-citation></ref>
<ref id="b7-jkstn-24-298"><label>7)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zavadil</surname> <given-names>J</given-names></name> <name><surname>Bottinger</surname> <given-names>EP</given-names></name></person-group> <article-title>TGF-beta and epithelial-to-mesenchymal transitions</article-title> <source>Oncogene</source> <year>2005</year><volume>24</volume> <fpage>5764</fpage><lpage>74</lpage></element-citation></ref>
<ref id="b8-jkstn-24-298"><label>8)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regele</surname> <given-names>H</given-names></name> <name><surname>Bohmig</surname> <given-names>GA</given-names></name> <name><surname>Habicht</surname> <given-names>A</given-names></name> <name><surname>Gollowitzer</surname> <given-names>D</given-names></name> <name><surname>Schillinger</surname> <given-names>M</given-names></name> <name><surname>Rockenschaub</surname> <given-names>S</given-names></name>, <etal/></person-group> <article-title>Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection</article-title> <source>J Am Soc Nephrol</source> <year>2002</year><volume>13</volume> <fpage>2371</fpage><lpage>80</lpage></element-citation></ref>
<ref id="b9-jkstn-24-298"><label>9)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solez</surname> <given-names>K</given-names></name> <name><surname>Vincenti</surname> <given-names>F</given-names></name> <name><surname>Filo</surname> <given-names>RS</given-names></name></person-group> <article-title>Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group</article-title> <source>Transplantation</source> <year>1998</year><volume>66</volume> <fpage>1736</fpage><lpage>40</lpage></element-citation></ref>
<ref id="b10-jkstn-24-298"><label>10)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Racusen</surname> <given-names>LC</given-names></name> <name><surname>Solez</surname> <given-names>K</given-names></name> <name><surname>Colvin</surname> <given-names>RB</given-names></name> <name><surname>Bonsib</surname> <given-names>SM</given-names></name> <name><surname>Castro</surname> <given-names>MC</given-names></name> <name><surname>Cavallo</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>The Banff 97 working classification of renal allograft pathology</article-title> <source>Kidney Int</source> <year>1999</year><volume>55</volume> <fpage>713</fpage><lpage>23</lpage></element-citation></ref>
<ref id="b11-jkstn-24-298"><label>11)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halloran</surname> <given-names>PF</given-names></name></person-group> <article-title>Call for revolution: a new approach to describing allograft deterioration</article-title> <source>Am J Transplant</source> <year>2002</year><volume>2</volume> <fpage>195</fpage><lpage>200</lpage></element-citation></ref>
<ref id="b12-jkstn-24-298"><label>12)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freese</surname> <given-names>P</given-names></name> <name><surname>Svalander</surname> <given-names>CT</given-names></name> <name><surname>Molne</surname> <given-names>J</given-names></name> <name><surname>Norden</surname> <given-names>G</given-names></name> <name><surname>Nyberg</surname> <given-names>G</given-names></name></person-group> <article-title>Chronic allograft nephropathy-biopsy finding and outcome</article-title> <source>Nephrol Dial Transplant</source> <year>2001</year><volume>16</volume> <fpage>2401</fpage><lpage>6</lpage></element-citation></ref>
<ref id="b13-jkstn-24-298"><label>13)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwano</surname> <given-names>M</given-names></name> <name><surname>Plieth</surname> <given-names>D</given-names></name> <name><surname>Danoff</surname> <given-names>TM</given-names></name> <name><surname>Xue</surname> <given-names>C</given-names></name> <name><surname>Okada</surname> <given-names>H</given-names></name> <name><surname>Neilson</surname> <given-names>EG</given-names></name></person-group> <article-title>Evidence that fibroblasts derive from epithelium during tissue fibrosis</article-title> <source>J Clin Invest</source> <year>2002</year><volume>110</volume> <fpage>341</fpage><lpage>50</lpage></element-citation></ref>
<ref id="b14-jkstn-24-298"><label>14)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y</given-names></name></person-group> <article-title>Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention</article-title> <source>J Am Soc Nephrol</source> <year>2004</year><volume>15</volume> <fpage>1</fpage><lpage>12</lpage></element-citation></ref>
<ref id="b15-jkstn-24-298"><label>15)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname> <given-names>ED</given-names></name> <name><surname>Zuk</surname> <given-names>A</given-names></name></person-group> <article-title>Transformations between epithelium and mesenchyme: normal, pathological and experimentally induced</article-title> <source>Am J Kidney Dis</source> <year>1995</year><volume>26</volume> <fpage>678</fpage><lpage>90</lpage></element-citation></ref>
<ref id="b16-jkstn-24-298"><label>16)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birchmeier</surname> <given-names>W</given-names></name> <name><surname>Birchmeier</surname> <given-names>C</given-names></name></person-group> <article-title>Epithelial-mesenchymal transitions in development and tumor progression</article-title> <source>EXS</source> <year>1995</year><volume>74</volume> <fpage>1</fpage><lpage>15</lpage></element-citation></ref>
<ref id="b17-jkstn-24-298"><label>17)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rastaldi</surname> <given-names>MP</given-names></name> <name><surname>Ferrario</surname> <given-names>F</given-names></name> <name><surname>Giardino</surname> <given-names>L</given-names></name> <name><surname>Dell&#x0027;Antonio</surname> <given-names>G</given-names></name> <name><surname>Grillo</surname> <given-names>C</given-names></name> <name><surname>Grillo</surname> <given-names>P</given-names></name>, <etal/></person-group> <article-title>Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies</article-title> <source>Kidney Int</source> <year>2002</year><volume>62</volume> <fpage>137</fpage><lpage>46</lpage></element-citation></ref>
<ref id="b18-jkstn-24-298"><label>18)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razzaque</surname> <given-names>MS</given-names></name> <name><surname>Le</surname> <given-names>VT</given-names></name> <name><surname>Taguchi</surname> <given-names>T</given-names></name></person-group> <article-title>Heat shock protein 47 and renal fibrogenesis</article-title> <source>Contrib Nephrol</source> <year>2005</year><volume>148</volume> <fpage>57</fpage><lpage>69</lpage></element-citation></ref>
<ref id="b19-jkstn-24-298"><label>19)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname> <given-names>K</given-names></name> <name><surname>Ozono</surname> <given-names>Y</given-names></name> <name><surname>Miyazaki</surname> <given-names>M</given-names></name> <name><surname>Koji</surname> <given-names>T</given-names></name> <name><surname>Shioshita</surname> <given-names>K</given-names></name> <name><surname>Furusu</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Interstitial expression of heat shock protein 47 and alpha-smooth muscle actin in renal allograft failure</article-title> <source>Nephrol Dial Transplant</source> <year>2000</year><volume>15</volume> <fpage>529</fpage><lpage>35</lpage></element-citation></ref>
<ref id="b20-jkstn-24-298"><label>20)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeisberg</surname> <given-names>M</given-names></name> <name><surname>Bonner</surname> <given-names>G</given-names></name> <name><surname>Maeshima</surname> <given-names>Y</given-names></name> <name><surname>Colorado</surname> <given-names>P</given-names></name> <name><surname>Muller</surname> <given-names>GA</given-names></name> <name><surname>Strutz</surname> <given-names>F</given-names></name> <etal/></person-group> <article-title>Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation</article-title> <source>Am J Pathol</source> <year>2001</year><volume>159</volume> <fpage>1313</fpage><lpage>21</lpage></element-citation></ref>
<ref id="b21-jkstn-24-298"><label>21)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jafar</surname> <given-names>TH</given-names></name> <name><surname>Stark</surname> <given-names>PC</given-names></name> <name><surname>Schmid</surname> <given-names>CH</given-names></name> <name><surname>Landa</surname> <given-names>M</given-names></name> <name><surname>Maschio</surname> <given-names>G</given-names></name> <name><surname>de Jong</surname> <given-names>PE</given-names></name> <etal/></person-group> <article-title>Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and an-giotensin-converting enzyme inhibition: a patient-level metaanalysis</article-title> <source>Ann Intern Med</source> <year>2003</year><volume>139</volume> <fpage>244</fpage><lpage>52</lpage></element-citation></ref>
<ref id="b22-jkstn-24-298"><label>22)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bijian</surname> <given-names>K</given-names></name> <name><surname>Cybulsky</surname> <given-names>AV</given-names></name></person-group> <article-title>Stress proteins in glomerular epithelial cell injury</article-title> <source>Contrib Nephrol</source> <year>2005</year><volume>148</volume> <fpage>8</fpage><lpage>20</lpage></element-citation></ref>
<ref id="b23-jkstn-24-298"><label>23)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoja</surname> <given-names>C</given-names></name> <name><surname>Corna</surname> <given-names>D</given-names></name> <name><surname>Camozzi</surname> <given-names>D</given-names></name> <name><surname>Cattaneo</surname> <given-names>D</given-names></name> <name><surname>Rottoli</surname> <given-names>D</given-names></name> <name><surname>Batani</surname> <given-names>C</given-names></name> <etal/></person-group> <article-title>How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach</article-title> <source>J Am Soc Nephrol</source> <year>2002</year><volume>13</volume> <fpage>2898</fpage><lpage>908</lpage></element-citation></ref>
<ref id="b24-jkstn-24-298"><label>24)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suthanthiran</surname> <given-names>M</given-names></name> <name><surname>Khanna</surname> <given-names>A</given-names></name> <name><surname>Cukran</surname> <given-names>D</given-names></name> <name><surname>Adhikarla</surname> <given-names>R</given-names></name> <name><surname>Sharma</surname> <given-names>VK</given-names></name> <name><surname>Singh</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients</article-title> <source>Kidney Int</source> <year>1998</year><volume>53</volume> <fpage>639</fpage><lpage>44</lpage></element-citation></ref>
<ref id="b25-jkstn-24-298"><label>25)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>MG</given-names></name> <name><surname>Joo</surname> <given-names>SH</given-names></name> <name><surname>Park</surname> <given-names>SK</given-names></name> <name><surname>Kim</surname> <given-names>JS</given-names></name> <name><surname>Hyun</surname> <given-names>SJ</given-names></name> <name><surname>Nam</surname> <given-names>ES</given-names></name> <etal/></person-group> <article-title>Correlation of hypoxia inducible factor-1&#x03B1; &#x0026; transforming grwth factor-1&#x03B2; expression and progression of renal allograft</article-title> <source>J Korean Soc Transplant</source> <year>2005</year><volume>19</volume> <fpage>131</fpage><lpage>6</lpage> <comment>(&#xBC15;&#xBBFC;&#xADFC;, &#xC8FC;&#xC120;&#xD615;, &#xBC15;&#xC131;&#xAE38;, &#xAE40;&#xC8FC;&#xC12D;, &#xD604;&#xC219;&#xC790;, &#xB0A8;&#xC740;&#xC219;, &#xB4F1;. &#xC2E0;&#xC0DD;&#xAC80;&#xC5D0;&#xC11C;&#xC758; Hypoxia Inducible Factor-1&#x03B1;, Transforming Growth Factor-&#x03B2;1 &#xBC1C;&#xD604;&#xACFC; &#xC774;&#xC2DD;&#xC2E0; &#xC608;&#xD6C4;&#xC640;&#xC758; &#xC5F0;&#xAD00;&#xC131;. &#xB300;&#xD55C;&#xC774;&#xC2DD;&#xD559;&#xD68C;&#xC9C0; 2005;19: 131&#x2013;6.)</comment></element-citation></ref>
<ref id="b26-jkstn-24-298"><label>26)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname> <given-names>M</given-names></name> <name><surname>Regele</surname> <given-names>H</given-names></name> <name><surname>Schillinger</surname> <given-names>M</given-names></name> <name><surname>Exner</surname> <given-names>M</given-names></name> <name><surname>Rasoul Rokenschaub</surname> <given-names>S</given-names></name> <name><surname>Wahrmann</surname> <given-names>M</given-names></name>, <etal/></person-group> <article-title>Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort</article-title> <source>Transplantation</source> <year>2004</year><volume>78</volume> <fpage>447</fpage><lpage>52</lpage></element-citation></ref>
<ref id="b27-jkstn-24-298"><label>27)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohmig</surname> <given-names>GA</given-names></name> <name><surname>Exner</surname> <given-names>M</given-names></name> <name><surname>Habicht</surname> <given-names>A</given-names></name> <name><surname>Schillinger</surname> <given-names>M</given-names></name> <name><surname>Lang</surname> <given-names>U</given-names></name> <name><surname>Kletzmayr</surname> <given-names>J</given-names></name> <etal/></person-group> <article-title>Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury</article-title> <source>J Am Soc Nephrol</source> <year>2002</year><volume>13</volume> <fpage>1091</fpage><lpage>9</lpage></element-citation></ref>
</ref-list>
<sec sec-type="display-objects">
<title>Figures and Tables</title>
<fig id="f1-jkstn-24-298" position="anchor">
<label>Fig. 1.</label>
<caption xml:lang="en"><p>E-cadherin expression in Implantation biopsy vs Functioning group (CAN) vs non functioning group (CAN), arrow (high expression), arrow head (low expression) (&#x00D7;100). (A) Implantation biopsy, high expression of E-cadherin. (B) CAN, Functioning group mild loss of expression of E-cadherin. (C) CAN, non functioning group entire loss of expression. Abbreviation: CAN, chronic allograft nephropathy.</p></caption>
<graphic xlink:href="jkstn-24-298f1.tif"/>
</fig>
<fig id="f2-jkstn-24-298" position="anchor">
<label>Fig. 2.</label>
<caption xml:lang="en"><p>HSP47 expression in Implantation biopsy vs Functioning group (CAN) vs non functioning group (CAN), arrow (high expression), arrow head (low expression) (&#x00D7;100). (A) Implantation biopsy, no expression of HSP47. (B) CAN, functioning group, low expression in tubule. (C) CAN, non functioning group, high expression in tubule and interstitium. Abbreviations: HSP, heat shock protein; CAN, chronic allograft nephropathy.</p></caption>
<graphic xlink:href="jkstn-24-298f2.tif"/>
</fig>
<fig id="f3-jkstn-24-298" position="anchor">
<label>Fig. 3.</label>
<caption xml:lang="en"><p>TGF-&#x00DF;1 expression in implantation biopsy vs functioning group (CAN) vs non functioning group (CAN), arrow (high expression), arrow head (low expression) (&#x00D7;100). (A) Implantation biopsy, no expression of TGF-&#x00DF;1. (B) CAN, Functioning group mild expression in interstitium. (C) CAN, non functioning group high expression in tubule &#x0026; inerstitium. Abbreviations: TGF, transforming growth factor; CAN, chronic allograft nephropathy.</p></caption>
<graphic xlink:href="jkstn-24-298f3.tif"/>
</fig>
<fig id="f4-jkstn-24-298" position="anchor">
<label>Fig. 4.</label>
<caption xml:lang="en"><p>Correlation of E-cadherin E-cadherin, HSP-47, TGF-&#x03B2;1, C4d expression and graft survivals after transplantation. (A) E-cadherin.(B) HSP-47. (C) TGF-b1. (D) C4d. Abbreviations: HSP, heat shock protein; TGF, transforming growth factor.</p></caption>
<graphic xlink:href="jkstn-24-298f4.tif"/>
</fig>
<table-wrap id="t1-jkstn-24-298" position="float">
<label>Table 1.</label>
<caption xml:lang="en"><p>Banff 97 diagnostic categories for renal allograft biopsies-update</p></caption>
<table frame="hsides" rules="all">
<thead>
<tr>
<th colspan="2" valign="middle" align="center">chronic/sclerosing allograft nephropathy Fibrosing changes in the allograft with or without features of true alloimmune injury to the graft may coincide with categories 2, 3 and 4.</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Grade</td>
<td valign="middle" align="left">Histologic finding</td>
</tr>
<tr>
<td valign="middle" align="left">Grade I (mild)</td>
<td valign="middle" align="left">Mild interstitial fibrosis and tubular atrophy without (a) or with (b) specific changes suggesting chronic rejection</td>
</tr>
<tr>
<td valign="middle" align="left">Grade II (moderate)</td>
<td valign="middle" align="left">Moderate interstitial fibrosis and tubular atrophy (a) or (b)</td>
</tr>
<tr>
<td valign="middle" align="left">Grade III (severe)</td>
<td valign="middle" align="left">Severe interstitial fibrosis and tubular atrophy and tubular loss (a) or (b)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="t2-jkstn-24-298" position="float">
<label>Table 2.</label>
<caption xml:lang="en"><p>Patients characteristics in post-transplant chronic allograft nephropathy</p></caption>
<table frame="hsides" rules="all">
<thead>
<tr>
<th valign="middle" align="center">Variables</th>
<th valign="middle" align="center">n&#x003D;42</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Gender (male/female)</td>
<td valign="middle" align="center">28/14</td>
</tr>
<tr>
<td valign="middle" align="left">Donor (living/deceased)</td>
<td valign="middle" align="center">28/14</td>
</tr>
<tr>
<td valign="middle" align="left">Recipient Age (year)</td>
<td valign="middle" align="center">41.6&#x00B1;10.2</td>
</tr>
<tr>
<td valign="middle" align="left">Donor Age (year)</td>
<td valign="middle" align="center">35.7&#x00B1;11.9</td>
</tr>
<tr>
<td valign="middle" align="left">Immunosuppressant (FK/CyA)</td>
<td valign="middle" align="center">30/12</td>
</tr>
<tr>
<td valign="middle" align="left">HLA mismatch (A, B, DR)</td>
<td valign="middle" align="center">2.3&#x00B1;0.9</td>
</tr>
<tr>
<td valign="middle" align="left">Timing of biopsy post KT (month)</td>
<td valign="middle" align="center">66.6&#x00B1;47.2</td>
</tr>
<tr>
<td valign="middle" align="left">Allograft rejection episode (&#x0025;)</td>
<td valign="middle" align="center">19.0 (8/42)</td>
</tr>
<tr>
<td valign="middle" align="left">Creatinine at biopsy (mmol/L)</td>
<td valign="middle" align="center">2.85&#x00B1;1.4</td>
</tr>
<tr>
<td valign="middle" align="left">Significant proteinuria (&#xFF1E;0.5 g/day)</td>
<td valign="middle" align="center">12/30</td>
</tr>
<tr>
<td valign="middle" align="left">Graft survival rate (&#x0025;)</td>
<td valign="middle" align="center">40.5 (17/42)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table2-fn1-jkstn-24-298"><p>Abbreviations: CyA, cyclosporin A; HLA, human leukocyte anti-gen; KT, kidney transplantation.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="t3-jkstn-24-298" position="float">
<label>Table 3.</label>
<caption xml:lang="en"><p>Correlation between Banff score and functioning graft/ graft loss</p></caption>
<table frame="hsides" rules="all">
<thead>
<tr>
<th valign="middle" align="center" rowspan="2">Banff score</th>
<th colspan="2" valign="middle" align="center">Biopsy</th>
<th valign="middle" align="center" rowspan="2"><italic>P</italic></th>
</tr>
<tr>
<th valign="middle" align="center">Functioning graft (n&#x003D;17)</th>
<th valign="middle" align="center">Graft loss (n&#x003D;25)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Chronic allograft</td>
<td valign="middle" align="center">6</td>
<td valign="middle" align="center">11</td>
<td valign="middle" align="center">0.573</td>
</tr>
<tr>
<td valign="middle" align="left">&#x3000; glomerulopathy (CG)</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="left">&#x00A0;</td>
</tr>
<tr>
<td valign="middle" align="left">Chronic interstitial fibrosis</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">12</td>
<td valign="middle" align="center">0.107</td>
</tr>
<tr>
<td valign="middle" align="left">&#x3000; (CI)</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="left">&#x00A0;</td>
</tr>
<tr>
<td valign="middle" align="left">Chronic tubular atrophy</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">18</td>
<td valign="middle" align="center">0.02</td>
</tr>
<tr>
<td valign="middle" align="left">&#x3000; (CT)</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="left">&#x00A0;</td>
</tr>
<tr>
<td valign="middle" align="left">Chronic vascular fibrous</td>
<td valign="middle" align="center">5</td>
<td valign="middle" align="center">15</td>
<td valign="middle" align="center">0.051</td>
</tr>
<tr>
<td valign="middle" align="left">intimal thickening (CV)</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="left">&#x00A0;</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="t4-jkstn-24-298" position="float">
<label>Table 4.</label>
<caption xml:lang="en"><p>Correlation between markers and proteinuria, serum creatinine</p></caption>
<table frame="hsides" rules="all">
<thead>
<tr>
<th valign="middle" align="center" rowspan="2" colspan="2">Marker</th>
<th colspan="2" valign="middle" align="center">Proteinuria</th>
<th valign="middle" align="center" rowspan="2"><italic>P</italic></th>
<th valign="middle" align="center" rowspan="2">Cr <sup><xref ref-type="table-fn" rid="table4-fn2-jkstn-24-298">a</xref></sup></th>
<th valign="middle" align="center" rowspan="2"><italic>P</italic></th>
</tr>
<tr>
<th valign="middle" align="center">(&#x002B;)</th>
<th valign="middle" align="center">(&#x2212;)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">E-cadherin</td>
<td valign="middle" align="center">(&#x002B;)</td>
<td valign="middle" align="center">11</td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">0.96</td>
<td valign="middle" align="center">2.75</td>
<td valign="middle" align="center">0.40</td>
</tr>
<tr>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="center">(&#x2212;)</td>
<td valign="middle" align="center">20</td>
<td valign="middle" align="center">9</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="center">3.04</td>
<td valign="middle" align="left">&#x00A0;</td>
</tr>
<tr>
<td valign="middle" align="left">HSP47</td>
<td valign="middle" align="center">(&#x002B;)</td>
<td valign="middle" align="center">11</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">0.019</td>
<td valign="middle" align="center">3.05</td>
<td valign="middle" align="center">0.477</td>
</tr>
<tr>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="center">(&#x2212;)</td>
<td valign="middle" align="center">1</td>
<td valign="middle" align="center">14</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="center">2.46</td>
<td valign="middle" align="left">&#x00A0;</td>
</tr>
<tr>
<td valign="middle" align="left">TGF-&#x00DF;1</td>
<td valign="middle" align="center">(&#x002B;)</td>
<td valign="middle" align="center">5</td>
<td valign="middle" align="center">20</td>
<td valign="middle" align="center">0.136</td>
<td valign="middle" align="center">3.10</td>
<td valign="middle" align="center">0.380</td>
</tr>
<tr>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="center">(&#x2212;)</td>
<td valign="middle" align="center">7</td>
<td valign="middle" align="center">10</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="center">2.40</td>
<td valign="middle" align="left">&#x00A0;</td>
</tr>
<tr>
<td valign="middle" align="left">C4d</td>
<td valign="middle" align="center">(&#x002B;)</td>
<td valign="middle" align="center">3</td>
<td valign="middle" align="center">9</td>
<td valign="middle" align="center">0.746</td>
<td valign="middle" align="center">4.14</td>
<td valign="middle" align="center">&#xFF1C;0.05</td>
</tr>
<tr>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="center">(&#x2212;)</td>
<td valign="middle" align="center">9</td>
<td valign="middle" align="center">21</td>
<td valign="middle" align="left">&#x00A0;</td>
<td valign="middle" align="center">2.37</td>
<td valign="middle" align="left">&#x00A0;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table4-fn1-jkstn-24-298"><p>Abbreviations: HSP, heat shock protein; TGF, transforming growth factor.</p></fn>
<fn id="table4-fn2-jkstn-24-298"><label>a</label><p>Value at biopsy.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</back>
</article>
